Solanezumab does not slow cognitive decline in preclinical A

Solanezumab does not slow cognitive decline in preclinical Alzheimer disease

Solanezumab does not slow cognitive decline in preclinical Alzheimer disease

medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Massachusetts , United States , Boston , Amsterdam , Noord Holland , Netherlands , Reisaa Sperling , Eli Lilly , Alzheimer Association International Conference , New England Journal , Association International Conference , Massachusetts General Hospital , Preclinical Alzheimer Cognitive Composite , Avid Radiopharmaceuticals , Preclinical Alzheimer ,